Trial intelligence / Profile preview

Dexmedetomidine for bronchoalveolar lavage in severe pneumonia

ChiCTR2100052571Phase 4Recruiting

Sponsor
Jining First People's Hospital
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in pneumonia (2 arms), sponsored by Jining First People's Hospital. Primary endpoints: Alveolar surfactant protein A and Blood gas analysis. Started Nov 2021; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

pneumonia

Beyond the preview

Go deeper on ChiCTR2100052571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call